EverspanExosome Therapy
Extracellular vesicles containing cellular communication molecules used for tissue repair and regenerative medicine applications.
Human Trials
15
620 participants
Risk Level
Monthly Cost
Highly variable based on source, preparation method, and treatment protocol
Quick Facts
- Category
- Therapy
- Research Field
- Regenerative Medicine
- Evidence Grade
- C+ – Early
- Risk Level
- High
- Monthly Cost
- $3.0k – $15.0k
- Human Trials
- 15
Research Velocity
Mechanism of Action
Exosomes are naturally occurring extracellular vesicles that facilitate intercellular communication by transferring proteins, lipids, and genetic material between cells. These nanoscale vesicles can modulate immune responses, promote tissue repair, reduce inflammation, and enhance cellular regeneration. When administered therapeutically, exosomes may influence recipient cell behavior through their molecular cargo, potentially triggering healing cascades and improving tissue function.
Overview
Exosome therapy represents an emerging frontier in regenerative medicine, utilizing naturally occurring extracellular vesicles to potentially promote healing and tissue repair. Research suggests these nanoscale particles, typically derived from mesenchymal stem cells or other cell types, may carry therapeutic cargo including growth factors, microRNAs, and proteins that could influence cellular behavior and promote regeneration. Early clinical studies have investigated applications ranging from wound healing and osteoarthritis to cardiovascular disease and neurological conditions.
While preliminary research indicates promising potential, exosome therapy remains largely experimental with significant variability in preparation methods, dosing protocols, and quality control standards. Studies suggest the therapeutic effects may depend heavily on the source cells, isolation techniques, and storage conditions. The field faces substantial challenges including standardization of manufacturing processes, establishing optimal delivery methods, and determining appropriate patient selection criteria for different applications.
Known Interactions
- May interact with immunosuppressive medications by modulating immune responses
- Potential interactions with anticoagulant therapy due to effects on platelet function
- May influence the effectiveness of certain biologics and cell-based therapies
Legal Status by Country
Your country (United States)
FDA considers investigational; available at some clinics under physician discretion
Available without prescription in:
Colombia, India, Mexico, Panama, Russia, Thailand, Turkey, UAE, United States
📍 = your selected country · ✈️ = medical tourism destination · Always verify current local regulations before travel.
Key Research
- 2023
Comprehensive review of therapeutic applications
- 2023
Recent human clinical trial data
- 2022Exosome-based therapeutics for cardiovascular disease: A systematic review
Clinical evidence in cardiovascular applications
- 2023Regulatory challenges and clinical translation of exosome therapies
Regulatory and safety considerations
Related Interventions
GDF11 (Growth Differentiation Factor 11)
Circulating protein factor that research suggests may restore youthful tissue regeneration and reverse age-related decline
Klotho Protein Therapy
Experimental protein therapy targeting the anti-aging hormone klotho to potentially reverse cellular aging and improve healthspan.
Mitochondrial Transplantation
Experimental procedure involving direct transplantation of healthy mitochondria into cells to restore cellular energy production
3D Organ Bioprinting
Research explores 3D bioprinting technology to create functional organs and tissues for transplantation and regenerative medicine applications.
Last verified: 2026-03-16